📰 Oncoextra Test News
Page 2 - Oncoextra Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Oncoextra Test. Real-time updates on events, politics, business and more.
April 12, 2024
Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]
April 7, 2024
Silvant Capital Management LLC lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 […]
April 7, 2024
Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]
April 6, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $70.00, for a total transaction of $140,000.00. Following the completion of the sale, the executive vice president now directly owns […]
April 6, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $70.00, for a total transaction of $140,000.00. Following the transaction, the executive vice president now owns 71,787 shares in the company, […]
April 5, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) fell 4.7% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $70.04 and last traded at $70.24. 1,996,026 shares changed hands during mid-day trading, a decline of 9% from the average session volume of 2,193,090 shares. The stock […]
April 5, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) shares traded down 4.7% on Wednesday after an insider sold shares in the company. The stock traded as low as $70.04 and last traded at $70.24. 1,996,026 shares were traded during trading, a decline of 9% from the average session volume of 2,193,090 shares. The stock had […]
April 4, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $70.00, for a total transaction of $140,000.00. Following the sale, the executive vice president now directly owns 73,787 shares in the […]
April 2, 2024
Perfromance Wealth Partners LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,737 shares of the medical research company’s stock after selling 565 shares during the period. […]
April 2, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]